Cargando…

PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY.

Detalles Bibliográficos
Autores principales: Cagigas, Maria Lastra, Rajakumar, Gayathiri, Skarratt, Kristen, Hayward, Rachael, Pelaia, Tiana, Ardjmand, Alireza, Vaughan, Lachlin, Fontana, Luigi, Fuller, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429809/
http://dx.doi.org/10.1097/01.HS9.0000974040.18942.3f
_version_ 1785090804663975936
author Cagigas, Maria Lastra
Rajakumar, Gayathiri
Skarratt, Kristen
Hayward, Rachael
Pelaia, Tiana
Ardjmand, Alireza
Vaughan, Lachlin
Fontana, Luigi
Fuller, Stephen
author_facet Cagigas, Maria Lastra
Rajakumar, Gayathiri
Skarratt, Kristen
Hayward, Rachael
Pelaia, Tiana
Ardjmand, Alireza
Vaughan, Lachlin
Fontana, Luigi
Fuller, Stephen
author_sort Cagigas, Maria Lastra
collection PubMed
description
format Online
Article
Text
id pubmed-10429809
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104298092023-08-17 PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY. Cagigas, Maria Lastra Rajakumar, Gayathiri Skarratt, Kristen Hayward, Rachael Pelaia, Tiana Ardjmand, Alireza Vaughan, Lachlin Fontana, Luigi Fuller, Stephen Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429809/ http://dx.doi.org/10.1097/01.HS9.0000974040.18942.3f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Cagigas, Maria Lastra
Rajakumar, Gayathiri
Skarratt, Kristen
Hayward, Rachael
Pelaia, Tiana
Ardjmand, Alireza
Vaughan, Lachlin
Fontana, Luigi
Fuller, Stephen
PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY.
title PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY.
title_full PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY.
title_fullStr PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY.
title_full_unstemmed PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY.
title_short PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROLLED TRIAL LEU-KETO STUDY.
title_sort pb1796: administration of a ketogenic diet for chemotherapy protection in acute leukemia patients: is it feasible, safe, and valuable? preliminary results of the randomized controlled trial leu-keto study.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429809/
http://dx.doi.org/10.1097/01.HS9.0000974040.18942.3f
work_keys_str_mv AT cagigasmarialastra pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy
AT rajakumargayathiri pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy
AT skarrattkristen pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy
AT haywardrachael pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy
AT pelaiatiana pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy
AT ardjmandalireza pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy
AT vaughanlachlin pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy
AT fontanaluigi pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy
AT fullerstephen pb1796administrationofaketogenicdietforchemotherapyprotectioninacuteleukemiapatientsisitfeasiblesafeandvaluablepreliminaryresultsoftherandomizedcontrolledtrialleuketostudy